Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine Journal Article


Authors: Folkert, M. R.; Bilsky, M. H.; Tom, A. K.; Oh, J. H.; Alektiar, K. M.; Laufer, I.; Tap, W. D.; Yamada, Y.
Article Title: Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine
Abstract: Purpose Conventional radiation treatment (20-40 Gy in 5-20 fractions, 2-5 Gy per fraction) for sarcoma metastatic to the spine provides subtherapeutic doses, resulting in poor durable local control (LC) (50%-77% at 1 year). Hypofractionated (HF) and/or single-fraction (SF) image-guided stereotactic radiosurgery (IG-SRS) may provide a more effective means of managing these lesions. Methods and Materials Patients with pathologically proven high-grade sarcoma metastatic to the spine treated with HF and SF IG-SRS were included. LC and overall survival (OS) were analyzed by the use of Kaplan-Meier statistics. Univariate and multivariate analyses were performed by the use of Cox regression with competing-risks analysis; all confidence intervals are 95%. Toxicities were assessed according to Common Terminology Criteria for Adverse Events, version 4.0. Results From May 2005 to November 11, 2012, 88 patients with 120 discrete metastases received HF (3-6 fractions; median dose, 28.5 Gy; n=52, 43.3%) or SF IG-SRS (median dose, 24 Gy; n=68, 56.7%). The median follow-up time was 12.3 months. At 12 months, LC was 87.9% (confidence interval [CI], 81.3%-94.5%), OS was 60.6% (CI, 49.6%-71.6%), and median survival was 16.9 months. SF IG-SRS demonstrated superior LC to HF IG-SRS (12-month LC of 90.8% [CI, 83%-98.6%] vs 84.1% [CI, 72.9%-95.3%] P=.007) and retained significance on multivariate analysis (P=.030, hazard ratio 0.345; CI, 0.132-0.901]. Treatment was well tolerated, with 1% acute grade 3 toxicity, 4.5% chronic grade 3 toxicity, and no grade >3 toxicities. Conclusions In the largest series of metastatic sarcoma to the spine to date, IG-SRS provides excellent LC in the setting of an aggressive disease with low radiation sensitivity and poor prognosis. Single-fraction IG-SRS is associated with the highest rates of LC with minimal toxicity. © 2014 Elsevier Inc. All rights reserved.
Keywords: adult; cancer survival; aged; middle aged; major clinical study; overall survival; fatigue; outcome assessment; follow up; esophagitis; radiotherapy; cohort analysis; angiosarcoma; radiation injury; risk assessment; sarcoma; confidence interval; fibrosarcoma; tumors; radiation dose fractionation; diagnosis; radiosensitivity; dermatitis; stereotactic radiosurgery; hemangiopericytoma; leiomyosarcoma; solitary fibrous tumor; spindle cell sarcoma; toxicity; acute toxicity; multi variate analysis; multivariant analysis; chondrosarcoma; wound complication; risk analysis; spine metastasis; myxosarcoma; radiation treatments; hypofractionated; fault tolerant computer systems; natural language processing systems; tracheoesophageal fistula; common terminology criteria; image guided radiotherapy; myelitis; chronic toxicity; cancer prognosis; methods and materials; very elderly; human; male; female; priority journal; article; financial data processing
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 88
Issue: 5
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2014-04-01
Start Page: 1085
End Page: 1091
Language: English
DOI: 10.1016/j.ijrobp.2013.12.042
PROVIDER: scopus
PUBMED: 24661662
DOI/URL:
Notes: Export Date: 1 May 2014 -- CODEN: IOBPD -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kaled M Alektiar
    333 Alektiar
  2. Yoshiya Yamada
    479 Yamada
  3. Mark H Bilsky
    319 Bilsky
  4. Michael Ryan Folkert
    36 Folkert
  5. Jung Hun Oh
    187 Oh
  6. William Douglas Tap
    372 Tap
  7. Ilya Laufer
    146 Laufer
  8. Ashlyn Tom
    14 Tom